Aytu biopharma regains nasdaq minimum bid price compliance

Englewood, co / accesswire / january 25, 2023 / aytu biopharma, inc. (the company or "aytu") (nasdaq:aytu), a commercial stage pharmaceutical and consumer health company providing pediatric-focused prescription drugs and cost-effective consumer health solutions, today announced that it received a written notification from the listing qualifications department of the nasdaq stock market, llc ("nasdaq") notifying the company that it has regained compliance with the nasdaq's minimum bid price requirement. on january 23, 2023, nasdaq confirmed in that for the ten consecutive business days, from january 6, 2023 to january 20, 2023, the closing bid price of the company's common stock has been at $1.00 per share or greater.
AYTU Ratings Summary
AYTU Quant Ranking